These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20441584)

  • 1. Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
    Ochoa CD; Yu L; Al-Ansari E; Hales CA; Quinn DA
    J Cardiothorac Surg; 2010 May; 5():32. PubMed ID: 20441584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity.
    Snow JB; Kitzis V; Norton CE; Torres SN; Johnson KD; Kanagy NL; Walker BR; Resta TC
    J Appl Physiol (1985); 2008 Jan; 104(1):110-8. PubMed ID: 17947499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells.
    Fredenburgh LE; Liang OD; Macias AA; Polte TR; Liu X; Riascos DF; Chung SW; Schissel SL; Ingber DE; Mitsialis SA; Kourembanas S; Perrella MA
    Circulation; 2008 Apr; 117(16):2114-22. PubMed ID: 18391113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.
    Mizuno S; Bogaard HJ; Kraskauskas D; Alhussaini A; Gomez-Arroyo J; Voelkel NF; Ishizaki T
    Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L753-61. PubMed ID: 21335523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide.
    Weissmann N; Nollen M; Gerigk B; Ardeschir Ghofrani H; Schermuly RT; Gunther A; Quanz K; Fink L; Hänze J; Rose F; Seeger W; Grimminger F
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H931-8. PubMed ID: 12433654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension.
    Wanstall JC; Gambino A; Jeffery TK; Cahill MM; Bellomo D; Hayward NK; Kay GF
    Cardiovasc Res; 2002 Aug; 55(2):361-8. PubMed ID: 12123775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling.
    Campen MJ; Paffett ML; Colombo ES; Lucas SN; Anderson T; Nysus M; Norenberg JP; Gershman B; Hesterman J; Hoppin J; Willis M
    PLoS One; 2014; 9(5):e97084. PubMed ID: 24811453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of thrombospondin-1 in serum and pulmonary arterioles of hypoxic pulmonary hypertension rats].
    Yang YJ; Zheng XW; Yang GL; Cheng DY; Zhang P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):839-42, 887. PubMed ID: 23387209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.
    Beloiartsev A; da Glória Rodrigues-Machado M; Zhou GL; Tan TC; Zazzeron L; Tainsh RE; Leyton P; Jones RC; Scherrer-Crosbie M; Zapol WM
    Am J Respir Cell Mol Biol; 2015 May; 52(5):563-70. PubMed ID: 25233285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.
    Fredenburgh LE; Ma J; Perrella MA
    Trends Cardiovasc Med; 2009 Feb; 19(2):31-7. PubMed ID: 19577709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of thrombospondin-1 in the lung of hypoxic pulmonary hypertension rats].
    Yang YJ; Cheng DY; Zheng XW; Li F; Yang GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):19-23. PubMed ID: 22455124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia.
    Kelland NF; Bagnall AJ; Morecroft I; Gulliver-Sloan FH; Dempsie Y; Nilsen M; Yanagisawa M; Maclean MR; Kotelevtsev YV; Webb DJ
    J Vasc Res; 2010; 47(1):16-22. PubMed ID: 19672104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
    Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
    J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
    Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
    Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia.
    Thomas BJ; Wanstall JC
    Eur J Pharmacol; 2003 Sep; 477(2):153-61. PubMed ID: 14519419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration.
    Laursen BE; Dam MY; Mulvany MJ; Simonsen U
    Vascul Pharmacol; 2008; 49(2-3):71-6. PubMed ID: 18499529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.